Sign In
Buy ESPR
$3.14
+0 (+0%)
At Close: Jun 03, 2026
Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
08:55am, Tuesday, 01'st Aug 2023
Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $1.05 per share a year ago.
Esperion to Report Second Quarter 2023 Financial Results on August 1
02:10am, Saturday, 15'th Jul 2023
ANN ARBOR, Mich., July 18, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report second quarter 2023 financial results before the market opens on Tuesday, August 1, 2023.
ANN ARBOR, Mich., July 07, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the presentation of a key abstract at the 2023 ASPC Congress on CVD Prevention taking place on July 21-23, 2
Why Is Esperion Therapeutics (ESPR) Down 6.9% Since Last Earnings Report?
12:38pm, Thursday, 08'th Jun 2023
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?
Esperion to Present New Key Science at the American Diabetes Association's 83rd Scientific Sessions 2023
08:00am, Thursday, 08'th Jun 2023
ANN ARBOR, Mich., June 08, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the presentation of key late breaking sessions at the American Diabetes Association's 83rd Scientific Sessio
7 Hot Penny Stocks To Buy In May According To Insiders
12:00pm, Tuesday, 16'th May 2023
Penny stocks to buy according to 7 insiders in May 2023. The post 7 Hot Penny Stocks To Buy In May According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock
3 Hot Penny Stocks To Buy In May According To Insiders
10:52am, Monday, 15'th May 2023
Penny stocks to buy according to 3 insiders in May 2023. The post 3 Hot Penny Stocks To Buy In May According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock
Esperion (ESPR) Q1 Earnings Miss Estimates, Sales Beat, Stock Up
11:26am, Wednesday, 10'th May 2023
Esperion (ESPR) reports mixed first-quarter 2023 results, wherein earnings miss and revenues beat estimates. The stock of the company surges 5% on Tuesday.
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
09:56am, Tuesday, 09'th May 2023
Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.93 per share a year ago.
7 Very Undervalued Penny Stocks to Buy in April 2023
05:39pm, Thursday, 06'th Apr 2023
Investors are attracted to penny stocks for their potential to provide exponential gains. It is very common to find such companies trading for fractions of their target price.
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)
07:28am, Wednesday, 29'th Mar 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Penny Stocks To Buy Now? 3 Short Squeeze Stock To Watch
02:14pm, Monday, 27'th Mar 2023
Short squeeze penny stocks for your watch list. The post Penny Stocks To Buy Now?
Esperion (ESPR) Plummets 54% Over Milestone Payment Row
02:31pm, Friday, 17'th Mar 2023
An SEC filing by Esperion (ESPR) reveals that partner Daiichi Sankyo disagrees with the company's assessment that cardiovascular outcome CLEAR study data would support milestone payments.
ESPR Stock: 54.27% Plummet Explanation
10:37pm, Thursday, 16'th Mar 2023
The stock price of Esperion Therapeutics Inc (NASDAQ: ESPR) plummeted by 54.27% in the most recent trading session. This is why.
Why Is Esperion Therapeutics (ESPR) Stock Down 60% Today?
08:48am, Thursday, 16'th Mar 2023
Esperion Therapeutics (NASDAQ: ESPR ) stock is taking a beating on Thursday as the company comes into conflict with Daiichi Sankyo Europe . The problem between these two companies has to do with miles
